Operating out of its headquarters in Bangkok, Thailand, NewGenIvf Group Limited specializes in delivering assisted reproductive services. The firm is committed to ...
NewGenIvf Group Limited (NIVF) is a healthcare-focused assisted reproductive services (ARS) company that helps patients access fertility treatments. The company’s core business centers on providing reproductive medicine options for individuals and couples seeking to build or expand their families. From the patient’s perspective, NIVF’s value proposition is access to a ...NewGenIvf Group Limited (NIVF) is a healthcare-focused assisted reproductive services (ARS) company that helps patients access fertility treatments. The company’s core business centers on providing reproductive medicine options for individuals and couples seeking to build or expand their families. From the patient’s perspective, NIVF’s value proposition is access to a diversified set of ART pathways—commonly including in-vitro fertilization (IVF), egg donation, and surrogacy—along with supporting or ancillary care intended to improve end-to-end treatment experience.
Business model and services: NIVF’s services align with the ARS industry, where clinical workflows, specialist expertise, and coordinated patient management are critical. Fertility treatment typically involves multi-step processes (consultation, diagnostic and monitoring work, treatment cycles, and follow-up), and NIVF’s portfolio indicates the company supports multiple routes depending on patient needs and medical suitability. In practice, this means the company’s operations likely require qualified clinical staff, lab/embryology capabilities (for IVF), coordinated donor/surrogacy-related processes where applicable, and operational systems to manage schedules, treatment milestones, and medical documentation.
Products and operational components: While NIVF is primarily a services company rather than a manufacturer, the “product” is the fertility treatment journey. Key cost drivers in such businesses generally include personnel and clinical specialists, laboratory and consumables, facilities and technology used for treatment and monitoring, and regulatory/quality compliance costs. The company’s stated focus on ancillary care suggests it also invests in supporting services beyond core procedures to help patients navigate the treatment pathway.
Financial/cost structure (high level): As a services operator, margins can be influenced by cycle throughput, utilization rates, cost of clinical labor, lab consumables, and complexity of cases (e.g., egg donation and surrogacy can introduce additional coordination and compliance costs). Operating results and valuation metrics may be volatile in early-stage or expanding healthcare service businesses due to ramp-up expenses, capacity build-out, and patient demand cycles. Based on the provided market data snapshot, NIVF is traded on Nasdaq and has ongoing liquidity through active trading.
Key people and governance: Wing Fung Alfred Siu is identified as the co-founder and has served as Chairman of the Board and Chief Executive Officer since 2019. Leadership continuity is important in healthcare service firms because clinical standards, partner networks (for donor/surrogacy where relevant), and operational execution are tightly linked to management oversight.
Company footprint: NIVF operates out of Bangkok, Thailand, and serves patients across its broader service footprint described as Asia Pacific-oriented access to fertility treatments. The company’s website (nivf.global) indicates a branded platform presence, consistent with a technology-driven or ecosystem-oriented approach referenced in some descriptions.
Wishes/strategic direction (inferred from positioning): The company’s stated commitment is to fulfill the desire for family through a variety of fertility treatments. That typically translates into ongoing expansion of service capacity, improvement of patient pathways, and strengthening of clinical outcomes and patient support—key factors for building trust and long-term demand in fertility care.
YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.
QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).
$4.7M
-13.0%
+11.1%
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.
$9.9M
+1981.8%
-145.6%
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.
+20.2%
-39.9%
+299.7%
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).
-226.9%
-962.9%
-78.2%
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.
+209.0%
+2263.1%
-141.0%
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.
$-16.7M
-100.5%
-4354.3%
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.
-352.8%
-130.5%
-3909.4%
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.
18.3%
+106.3%
-2.5%
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.
3.12x
+167.5%
-9.0%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.
